Scientific Reports · 2017 · 55 citations · 47 references
MedicineNeurosciencePharmacologyMolecular NeurobiologyMolecular NeuroscienceNeuropharmacologyAcute Ischemic StrokeCerebrovascular DiseaseNeuroprotectionNeuroprotective PharmacologyStrokeStroke PharmacotherapyCerebral Ischemia NeuroprotectionCerebral Ischemia Reperfusion InjuryGlycine ReceptorsIschemic Stroke PathophysiologyNeurobehavioral AlterationsNmda Receptor AntagonistsNmda ReceptorsStroke Neuroprotection
NMDA receptor (NMDAR) is known for its ionotropic function. But recent evidence suggests that NMDAR also has a non-ionotropic property. To determine the role of non-ionotropic activity of NMDARs in clinical relevant conditions, we tested the effect of glycine, a co-agonist of NMDARs, in rat middle cerebral artery occlusion (MCAO), an animal model of cerebral ischemia-reperfusion injury after the animals were injected with the NMDAR channel blocker MK-801 and the glycine receptor antagonist strychnine. We show that glycine reduces the infarct volume in the brain of ischemic stroke animals pre-injected with MK-801 and strychnine. The effect of glycine is sensitive to the antagonist of glycine-GluN1 binding site and blocked by Akt inhibition. In the neurobehavioral tests, glycine improves the functional recovery of stroke animals pre-injected with MK-801 and strychnine. This study suggests that glycine-induced neuroprotection is mediated in part by the non-ionotropic activity of NMDARs via Akt activation in cerebral ischemia-reperfusion injury.
47
The glutamate receptor ion channels.
Raymond Dingledine, Karin Borges, Derek Bowie et al. · PubMed · 1999 · 1.7K citations
A Semiautomated Method for Measuring Brain Infarct Volume
Raymond A. Swanson, Matthew T. Morton, George Tsao-Wu et al. · Journal of Cerebral Blood Flow & Metabolism · 1990 · 1.7K citations
Medicine, Neurology, Neuroscience +16
J Chen, Paul R. Sanberg, Y Li et al. · Stroke · 2001 · 1.4K citations · Full text
Medicine, Neurobiology, Neuroscience +17